Jennifer A. L. Smith joined CTI BioPharma in November 2018 as Senior Vice President, Biometrics. Dr. Smith has more than 20 years of experience in pharmaceutical development including leading data management, statistical programming, biostatistics, and clinical operations groups and regulatory interactions including NDA and EMA filings in oncology and SAG and CHMP oral explanations. She joined CTI after Sunesis Pharmaceuticals (Vice President, Biometrics) where she built and led the biometrics team and provided leadership in their development program in AML. Prior to joining Sunesis, Dr. Smith held a number of roles including Senior Director, Biometrics at BiPar Sciences in support of their PARP inhibitor program primarily in breast, lung and ovarian cancer; Director, Biometrics at Geron CorporaSon where she supported the regenerative medicine and oncology areas; and Director, Biostatistics at Pharmacyclics, primarily focused on oncology. Dr. Smith received a B.Sc. in Psychology from the University of Toronto, an M.A. in Psychology from Stanford University, an M.S. in Statistics from Stanford University, and a Ph.D. in Neuropsychology from Stanford University.